Table 1 The socio-demographic factors associated with the prescription of an anti-obesity medication and measures of clustering at the practice level
Women | Men | |||||
|---|---|---|---|---|---|---|
Total population (% on medication) | OR1(95% CI) | P-value | Total population (% on medication) | OR1(95% CI) | P-value | |
Age group | ||||||
16-24 | 127 719 (0.9) | 0.29 (0.27, 0.31) | <0.001 | 133 610 (0.1) | 0.15 (0.13, 0.18) | <0.001 |
25-34 | 132 355 (2.2) | 0.71 (0.68, 0.75) | <0.001 | 135 349 (0.4) | 0.49 (0.44, 0.55) | <0.001 |
35-44 | 136 022 (3.0) | 1.00 | 141 154 (0.7) | 1.00 | ||
45-54 | 123 844 (2.9) | 0.98 (0.93, 1.02) | 0.35 | 127 073 (0.9) | 1.29 (1.19, 1.40) | <0.001 |
55-64 | 96 110 (2.6) | 0.88 (0.84, 0.93) | <0.001 | 96 422 (1.0) | 1.42 (1.30, 1.55) | <0.001 |
65-74 | 72 726 (1.5) | 0.50 (0.46, 0.53) | <0.001 | 65 679 (0.7) | 0.98 (0.88, 1.09) | 0.71 |
75+ | 61 728 (0.3) | 0.09 (0.08, 0.10) | <0.001 | 39 721 (0.2) | 0.22 (0.17, 0.28) | <0.001 |
Settlement band | ||||||
Urban | 290 578 (2.5) | 1.00 | 278 807 (0.7) | 1.00 | ||
Intermediate | 248 335 (2.0) | 0.97 (0.89, 1.05) | 0.43 | 239 862 (0.6) | 0.90 (0.80, 1.01) | 0.065 |
Rural | 199 655 (1.6) | 0.86 (0.79, 0.93) | 0.001 | 208 669 (0.5) | 0.81 (0.72, 0.91) | <0.001 |
Area deprivation | ||||||
Least deprived | 154 850 (1.6) | 1.00 | 149 806 (0.5) | 1.00 | ||
2nd | 162 180 (1.8) | 1.22 (1.15, 1.30) | <0.001 | 159 870 (0.6) | 1.19 (1.08, 1.32) | 0.001 |
3rd | 131 458 (2.0) | 1.45 (1.36, 1.54) | <0.001 | 129 325 (0.5) | 1.16 (1.04, 1.30) | 0.009 |
4th | 149 087 (2.2) | 1.64 (1.55, 1.74) | <0.001 | 146 440 (0.6) | 1.28 (1.15, 1.42) | <0.001 |
Most deprived | 140 993 (2.9) | 1.95 (1.83, 2.07) | <0.001 | 141 897 (0.8) | 1.64 (1.47, 1.82) | <0.001 |
Measures of variation or clustering | ||||||
Practice level variance (SE) | 0.25 (0.024) | 0.21 (0.026) | ||||
Variance Partition Coefficient (%) | 7.2 | 6.1 | ||||
Median Odds Ratio | 1.61 | 1.55 | ||||